메뉴 건너뛰기




Volumn 29, Issue 3, 2015, Pages 111-116

Barriers to antiretroviral therapy adherence and plasma HIV RNA suppression among AIDS clinical trials group study participants

Author keywords

[No Author keywords available]

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; VIRUS RNA;

EID: 84929325992     PISSN: 10872914     EISSN: 15577449     Source Type: Journal    
DOI: 10.1089/apc.2014.0255     Document Type: Article
Times cited : (27)

References (51)
  • 1
    • 0035876041 scopus 로고    scopus 로고
    • Non-adherence to highly active antiretroviral therapy predicts progression to AIDS
    • Bangsberg DR, Perry S, Charlebois ED, et al. Non-adherence to highly active antiretroviral therapy predicts progression to AIDS. AIDS 2001;15:1181-1183.
    • (2001) AIDS , vol.15 , pp. 1181-1183
    • Bangsberg, D.R.1    Perry, S.2    Charlebois, E.D.3
  • 3
    • 0037013038 scopus 로고    scopus 로고
    • Intermittent use of triple-combination therapy is predictive of mortality at baseline and after 1 year of follow-up
    • Hogg RS, Heath K, Bangsberg D, et al. Intermittent use of triple-combination therapy is predictive of mortality at baseline and after 1 year of follow-up. AIDS 2002;16:1051-1058.
    • (2002) AIDS , vol.16 , pp. 1051-1058
    • Hogg, R.S.1    Heath, K.2    Bangsberg, D.3
  • 4
    • 0142017677 scopus 로고    scopus 로고
    • World Health Organization In: World Health Organization, ed. Geneva
    • World Health Organization. Adherence to Long-Term Therapies: Evidence for Action. In: World Health Organization, ed. Geneva, 2003.
    • (2003) Adherence to Long-Term Therapies: Evidence for Action
  • 5
    • 33845359660 scopus 로고    scopus 로고
    • The elusive gold standard. Future perspectives for HIV adherence assessment and intervention
    • Chesney MA. The elusive gold standard. Future perspectives for HIV adherence assessment and intervention. J Acq Immun Def Synd 2006;43:S149-S155.
    • (2006) J Acq Immun Def Synd , vol.43 , pp. S149-S155
    • Chesney, M.A.1
  • 6
    • 34247583029 scopus 로고    scopus 로고
    • Adherence to nonnucleoside reverse transcriptase inhibitor-based HIV therapy and virologic outcomes
    • Nachega JB, Hislop M, Dowdy DW, Chaisson RE, Regensberg L, Maartens G. Adherence to nonnucleoside reverse transcriptase inhibitor-based HIV therapy and virologic outcomes. Ann Int Med 2007;146:564-573.
    • (2007) Ann Int Med , vol.146 , pp. 564-573
    • Nachega, J.B.1    Hislop, M.2    Dowdy, D.W.3    Chaisson, R.E.4    Regensberg, L.5    Maartens, G.6
  • 7
    • 84929343565 scopus 로고    scopus 로고
    • Avoidable Costs in U.S. Healthcare: The 200 Billion Opportunity from Using Medicines More Responsibly. 2013. Parsippany, NJ: IMS Institute for Healthcare Informatics
    • Aitken M, Valkova S. Avoidable Costs in U.S. Healthcare: The 200 Billion Opportunity from Using Medicines More Responsibly. 2013. Parsippany, NJ: IMS Institute for Healthcare Informatics. Available at: http://www.imshealth.com/deployedfiles/imshealth/Global/Content/Corporate/IMS%20Institute/RUOM-2013/IHII-Responsible-Use- Medicines-2013.pdf
    • Aitken, M.1    Valkova, S.2
  • 8
    • 34247560160 scopus 로고    scopus 로고
    • HIV-infected patients receiving lopinavir/ritonavir-based antiretroviral therapy achieve high rates of virologic suppression despite adherence rates less than 95%
    • Shuter J, Sarlo JA, Kanmaz TJ, Rode RA, Zingman BS. HIV-infected patients receiving lopinavir/ritonavir-based antiretroviral therapy achieve high rates of virologic suppression despite adherence rates less than 95%. J Acq Immun Def 2007;45:4-8.
    • (2007) J Acq Immun Def , vol.45 , pp. 4-8
    • Shuter, J.1    Sarlo, J.A.2    Kanmaz, T.J.3    Rode, R.A.4    Zingman, B.S.5
  • 9
    • 33748642352 scopus 로고    scopus 로고
    • Less than 95% adherence to nonnucleoside reverse-transcriptase inhibitor therapy can lead to viral suppression
    • Bangsberg DR. Less than 95% adherence to nonnucleoside reverse-transcriptase inhibitor therapy can lead to viral suppression. Clin Infect Dis 2006;43:939-941.
    • (2006) Clin Infect Dis , vol.43 , pp. 939-941
    • Bangsberg, D.R.1
  • 10
    • 36048981531 scopus 로고    scopus 로고
    • Effect of adherence to HAART on viroloaic outcome and on the selection of resistance-conferring mutations in NNRTI-or PI-Treated patients
    • Maggiolo F, Airoldi M, Kleinloog HD, et al. Effect of adherence to HAART on viroloaic outcome and on the selection of resistance-conferring mutations in NNRTI-or PI-Treated patients. HIV Clin Trials 2007;8:282-292.
    • (2007) HIV Clin Trials , vol.8 , pp. 282-292
    • Maggiolo, F.1    Airoldi, M.2    Kleinloog, H.D.3
  • 11
    • 33746902816 scopus 로고    scopus 로고
    • Adherence to antiretroviral therapy in sub-Saharan Africa and North America: A meta-analysis
    • Mills EJ, Nachega JB, Buchan I, et al. Adherence to antiretroviral therapy in sub-Saharan Africa and North America: A meta-analysis. JAMA 2006;296:679-690.
    • (2006) JAMA , vol.296 , pp. 679-690
    • Mills, E.J.1    Nachega, J.B.2    Buchan, I.3
  • 12
    • 84872678512 scopus 로고    scopus 로고
    • Barriers to medication adherence in behaviorally and perinatally infected youth living with HIV
    • MacDonell K, Naar-King S, Huszti H, Belzer M. Barriers to medication adherence in behaviorally and perinatally infected youth living with HIV. AIDS Behav 2013;17:86-93.
    • (2013) AIDS Behav , vol.17 , pp. 86-93
    • Macdonell, K.1    Naar-King, S.2    Huszti, H.3    Belzer, M.4
  • 13
    • 0037345510 scopus 로고    scopus 로고
    • Barriers to HAART adherence among human immunodeficiency virus-infected adolescents
    • Murphy DA, Sarr M, Durako SJ, et al. Barriers to HAART adherence among human immunodeficiency virus-infected adolescents. Arch Pediatr Adolesc Med 2003;157:249-255.
    • (2003) Arch Pediatr Adolesc Med , vol.157 , pp. 249-255
    • Murphy, D.A.1    Sarr, M.2    Durako, S.J.3
  • 14
    • 84860591105 scopus 로고    scopus 로고
    • Barriers to medication adherence in HIV-infected children and youth based on self-and caregiver report
    • Buchanan AL, Montepiedra G, Sirois PA, et al. Barriers to medication adherence in HIV-infected children and youth based on self-and caregiver report. Pediatrics 2012;129: e1244-e1251.
    • (2012) Pediatrics , vol.129 , pp. e1244-e1251
    • Buchanan, A.L.1    Montepiedra, G.2    Sirois, P.A.3
  • 15
    • 33845286853 scopus 로고    scopus 로고
    • Adherence to HAART: A systematic review of developed and developing nation patient-reported barriers and facilitators
    • Mills EJ, Nachega JB, Bangsberg DR, et al. Adherence to HAART: A systematic review of developed and developing nation patient-reported barriers and facilitators. PLoS Med 2006;3:e438.
    • (2006) PLoS Med , vol.3 , pp. e438
    • Mills, E.J.1    Nachega, J.B.2    Bangsberg, D.R.3
  • 16
    • 0347708659 scopus 로고    scopus 로고
    • Barriers and successful strategies to antiretroviral adherence among HIV-infected monolingual Spanish-speaking patients
    • Murphy DA, Roberts KJ, Hoffman D, Molina A, Lu MC. Barriers and successful strategies to antiretroviral adherence among HIV-infected monolingual Spanish-speaking patients. AIDS Care 2003;15:217-230.
    • (2003) AIDS Care , vol.15 , pp. 217-230
    • Murphy, D.A.1    Roberts, K.J.2    Hoffman, D.3    Molina, A.4    Lu, M.C.5
  • 17
    • 24644507807 scopus 로고    scopus 로고
    • A programmable prompting device improves adherence to highly active antiretroviral therapy in HIV-infected subjects with memory impairment
    • Andrade AS, McGruder HF, Wu AW, et al. A programmable prompting device improves adherence to highly active antiretroviral therapy in HIV-infected subjects with memory impairment. Clin Infect Dis 2005;41:875-882.
    • (2005) Clin Infect Dis , vol.41 , pp. 875-882
    • Andrade, A.S.1    McGruder, H.F.2    Wu, A.W.3
  • 18
    • 33845367426 scopus 로고    scopus 로고
    • Sustained benefit from a long-term antiretroviral adherence intervention. Results of a large randomized clinical trial
    • Mannheimer SB, Morse E, Matts JP, et al. Sustained benefit from a long-term antiretroviral adherence intervention. Results of a large randomized clinical trial. J Acq Immun Def Synd 2006;43:S41-S47.
    • (2006) J Acq Immun Def Synd , vol.43 , pp. S41-S47
    • Mannheimer, S.B.1    Morse, E.2    Matts, J.P.3
  • 19
    • 0037391696 scopus 로고    scopus 로고
    • Qualitative and quantitative assessments of HAART adherence of substance-abusing women
    • Powell-Cope GM, White J, Henkelman EJ, Turner BJ. Qualitative and quantitative assessments of HAART adherence of substance-abusing women. AIDS Care 2003;15: 239-249.
    • (2003) AIDS Care , vol.15 , pp. 239-249
    • Powell-Cope, G.M.1    White, J.2    Henkelman, E.J.3    Turner, B.J.4
  • 20
    • 0344735833 scopus 로고    scopus 로고
    • Use of an on-line pager system to increase adherence to antiretroviral medications
    • Safren SA, Hendriksen ES, Desousa N, Boswell SL, Mayer KH. Use of an on-line pager system to increase adherence to antiretroviral medications. AIDS Care 2003;15:787-793.
    • (2003) AIDS Care , vol.15 , pp. 787-793
    • Safren, S.A.1    Hendriksen, E.S.2    Desousa, N.3    Boswell, S.L.4    Mayer, K.H.5
  • 21
    • 0001696152 scopus 로고    scopus 로고
    • Selfreported adherence to antiretroviral medications among participants in HIV clinical trials: The AACTG Adherence Instruments
    • Chesney MA, Ickovics JR, Chambers DB, et al. Selfreported adherence to antiretroviral medications among participants in HIV clinical trials: The AACTG Adherence Instruments. AIDS Care 2000;12:255-266.
    • (2000) AIDS Care , vol.12 , pp. 255-266
    • Chesney, M.A.1    Ickovics, J.R.2    Chambers, D.B.3
  • 22
    • 70349768299 scopus 로고    scopus 로고
    • Antiretroviral therapy in acute and recent HIV infection: A prospective multicenter stratified trial of intentionally interrupted treatment
    • Volberding P, Demeter L, Bosch RJ, et al. Antiretroviral therapy in acute and recent HIV infection: A prospective multicenter stratified trial of intentionally interrupted treatment. AIDS 2009;23:1987-1995.
    • (2009) AIDS , vol.23 , pp. 1987-1995
    • Volberding, P.1    Demeter, L.2    Bosch, R.J.3
  • 23
    • 0035068386 scopus 로고    scopus 로고
    • ACTG (AIDS Clinical Trials Group) 384: A strategy trial comparing consecutive treatments for HIV-1
    • Smeaton LM, DeGruttola V, Robbins GK, Shafer RW. ACTG (AIDS Clinical Trials Group) 384: A strategy trial comparing consecutive treatments for HIV-1. Controlled Clin Trials 2001;22:142-159.
    • (2001) Controlled Clin Trials , vol.22 , pp. 142-159
    • Smeaton, L.M.1    Degruttola, V.2    Robbins, G.K.3    Shafer, R.W.4
  • 24
    • 0344149561 scopus 로고    scopus 로고
    • Comparison of four-drug regimens and pairs of sequential three-drug regimens as initial therapy for HIV-1 infection
    • Shafer RW, Smeaton LM, Robbins GK, et al. Comparison of four-drug regimens and pairs of sequential three-drug regimens as initial therapy for HIV-1 infection. New Engl J Med 2003;349:2304-2315.
    • (2003) New Engl J Med , vol.349 , pp. 2304-2315
    • Shafer, R.W.1    Smeaton, L.M.2    Robbins, G.K.3
  • 25
    • 0141612909 scopus 로고    scopus 로고
    • A randomized trial of 2 different 4-drug antiretroviral regimens versus a 3-drug regimen, in advanced human immunodeficiency virus disease
    • Fischl MA, Ribaudo HJ, Collier AC, et al. A randomized trial of 2 different 4-drug antiretroviral regimens versus a 3-drug regimen, in advanced human immunodeficiency virus disease. J Infect Dis 2003;188:625-634.
    • (2003) J Infect Dis , vol.188 , pp. 625-634
    • Fischl, M.A.1    Ribaudo, H.J.2    Collier, A.C.3
  • 26
    • 67650470636 scopus 로고    scopus 로고
    • Modified directly observed antiretroviral therapy compared with self-administered therapy in treatment-naive HIV-1-infected patients. A randomized trial
    • Gross R, Tierney C, Andrade A, et al. Modified directly observed antiretroviral therapy compared with self-administered therapy in treatment-naive HIV-1-infected patients. A randomized trial. Arch Intern Med 2009;169:1224-1232.
    • (2009) Arch Intern Med , vol.169 , pp. 1224-1232
    • Gross, R.1    Tierney, C.2    Andrade, A.3
  • 27
    • 77749329017 scopus 로고    scopus 로고
    • Comparison of oncedaily versus twice-daily combination antiretroviral therapy in treatment-naive patients: Results of AIDS Clinical Trials Group (ACTG) A5073, a 48-week randomized controlled trial
    • Flexner C, Tierney C, Gross R, et al. Comparison of oncedaily versus twice-daily combination antiretroviral therapy in treatment-naive patients: Results of AIDS Clinical Trials Group (ACTG) A5073, a 48-week randomized controlled trial. Clin Infect Dis 2010;50:1041-1052.
    • (2010) Clin Infect Dis , vol.50 , pp. 1041-1052
    • Flexner, C.1    Tierney, C.2    Gross, R.3
  • 28
    • 9144272257 scopus 로고    scopus 로고
    • A randomized trial of nelfinavir and abacavir in combination with efavirenz and adefovir dipivoxil in HIV-1-infected persons with virological failure receiving indinavir
    • Hammer SM, Bassett R, Squires KE, et al. A randomized trial of nelfinavir and abacavir in combination with efavirenz and adefovir dipivoxil in HIV-1-infected persons with virological failure receiving indinavir. Antivir Ther 2003;8:507-518.
    • (2003) Antivir Ther , vol.8 , pp. 507-518
    • Hammer, S.M.1    Bassett, R.2    Squires, K.E.3
  • 29
    • 78751559513 scopus 로고    scopus 로고
    • A randomized, placebo-controlled trial of abacavir intensification in HIV-1-infected adults with virologic suppression on a protease inhibitor-containing regimen
    • Hammer SM, Ribaudo H, Bassett R, et al. A randomized, placebo-controlled trial of abacavir intensification in HIV-1-infected adults with virologic suppression on a protease inhibitor-containing regimen. HIV Clin Trials 2010;11:312-324.
    • (2010) HIV Clin Trials , vol.11 , pp. 312-324
    • Hammer, S.M.1    Ribaudo, H.2    Bassett, R.3
  • 30
    • 0037055027 scopus 로고    scopus 로고
    • Dual vs single protease inhibitor therapy following antiretroviral treatment failure-A randomized trial
    • Hammer SM, Vaida F, Bennett KK, et al. Dual vs single protease inhibitor therapy following antiretroviral treatment failure-A randomized trial. JAMA 2002;288:169-180.
    • (2002) JAMA , vol.288 , pp. 169-180
    • Hammer, S.M.1    Vaida, F.2    Bennett, K.K.3
  • 31
    • 0035958764 scopus 로고    scopus 로고
    • Effects of treatment intensification with hydroxyurea in HIV-infected patients with virologic suppression
    • Havlir DV, Gilbert PB, Bennett K, et al. Effects of treatment intensification with hydroxyurea in HIV-infected patients with virologic suppression. AIDS 2001;15:1379-1388.
    • (2001) AIDS , vol.15 , pp. 1379-1388
    • Havlir, D.V.1    Gilbert, P.B.2    Bennett, K.3
  • 32
    • 33846596702 scopus 로고    scopus 로고
    • Randomized open-label trial of two simplified, class-sparing regimens following a first suppressive three or four-drug regimen
    • Fischl MA, Collier AC, Mukherjee AL, et al. Randomized open-label trial of two simplified, class-sparing regimens following a first suppressive three or four-drug regimen. AIDS 2007;21:325-333.
    • (2007) AIDS , vol.21 , pp. 325-333
    • Fischl, M.A.1    Collier, A.C.2    Mukherjee, A.L.3
  • 33
    • 67149097953 scopus 로고    scopus 로고
    • Predictive value of pharmacokinetics-adjusted phenotypic susceptibility on response to ritonavir-enhanced protease inhibitors (PIs) in human immunodeficiency virus-infected subjects failing prior PI therapy
    • Eron JJ Jr., Park JG, Haubrich R, et al. Predictive value of pharmacokinetics-adjusted phenotypic susceptibility on response to ritonavir-enhanced protease inhibitors (PIs) in human immunodeficiency virus-infected subjects failing prior PI therapy. Antimicrob Agents Chemother 2009;53:2335-2341.
    • (2009) Antimicrob Agents Chemother , vol.53 , pp. 2335-2341
    • Eron, J.J.1    Park, J.G.2    Haubrich, R.3
  • 34
    • 20144365012 scopus 로고    scopus 로고
    • Combining fosamprenavir with lopinavir/ritonavir substantially reduces amprenavir and lopinavir exposure: ACTG protocol A5143 results
    • Kashuba AD, Tierney C, Downey GF, et al. Combining fosamprenavir with lopinavir/ritonavir substantially reduces amprenavir and lopinavir exposure: ACTG protocol A5143 results. AIDS 2005;19:145-152.
    • (2005) AIDS , vol.19 , pp. 145-152
    • Kashuba, A.D.1    Tierney, C.2    Downey, G.F.3
  • 35
    • 44949247362 scopus 로고    scopus 로고
    • Randomized study of dual versus single ritonavir-enhanced protease inhibitors for protease inhibitor-experienced patients with HIV
    • Collier AC, Tierney C, Downey GF, et al. Randomized study of dual versus single ritonavir-enhanced protease inhibitors for protease inhibitor-experienced patients with HIV. HIV Clin Trials 2008;9:91-102.
    • (2008) HIV Clin Trials , vol.9 , pp. 91-102
    • Collier, A.C.1    Tierney, C.2    Downey, G.F.3
  • 36
    • 38149142836 scopus 로고    scopus 로고
    • Prior illicit drug use and missed prenatal vitamins predict nonadherence to antiretroviral therapy in pregnancy: Adherence analysis A5084
    • Cohn SE, Umbleja T, Mrus J, Bardeguez AD, Andersen JW, Chesney MA. Prior illicit drug use and missed prenatal vitamins predict nonadherence to antiretroviral therapy in pregnancy: Adherence analysis A5084. AIDS Patient Care STDs 2008;22:29-40.
    • (2008) AIDS Patient Care STDs , vol.22 , pp. 29-40
    • Cohn, S.E.1    Umbleja, T.2    Mrus, J.3    Bardeguez, A.D.4    Andersen, J.W.5    Chesney, M.A.6
  • 37
    • 0037090280 scopus 로고    scopus 로고
    • Association of adherence to Mycobacterium avium complex prophylaxis and antiretroviral therapy with clinical outcomes in Acquired Immunodeficiency Syndrome
    • Cohn SE, Kammann E, Williams P, Currier JS, Chesney MA. Association of adherence to Mycobacterium avium complex prophylaxis and antiretroviral therapy with clinical outcomes in Acquired Immunodeficiency Syndrome. Clin Infect Dis 2002;34:1129-1136.
    • (2002) Clin Infect Dis , vol.34 , pp. 1129-1136
    • Cohn, S.E.1    Kammann, E.2    Williams, P.3    Currier, J.S.4    Chesney, M.A.5
  • 38
    • 79956323731 scopus 로고    scopus 로고
    • Association of ongoing drug and alcohol use with non-adherence to antiretroviral therapy and higher risk of AIDS and death: Results from ACTG 362
    • Cohn SE, Jiang HY, McCutchan JA, et al. Association of ongoing drug and alcohol use with non-adherence to antiretroviral therapy and higher risk of AIDS and death: Results from ACTG 362. AIDS Care 2011;23:775-785.
    • (2011) AIDS Care , vol.23 , pp. 775-785
    • Cohn, S.E.1    Jiang, H.Y.2    McCutchan, J.A.3
  • 39
    • 0000095552 scopus 로고
    • A heteroskedasticity-consistent covariance matrix estimator and a direct test for heteroskedasticity
    • White H. A heteroskedasticity-consistent covariance matrix estimator and a direct test for heteroskedasticity. Econometrics 1980;48:817-838.
    • (1980) Econometrics , vol.48 , pp. 817-838
    • White, H.1
  • 40
    • 77950527840 scopus 로고    scopus 로고
    • Using dominance analysis to determine predictor importance in logistic regression
    • Azen R, Traxel NM. Using dominance analysis to determine predictor importance in logistic regression. J Edu Behav Statistics 2009;34:319-347.
    • (2009) J Edu Behav Statistics , vol.34 , pp. 319-347
    • Azen, R.1    Traxel, N.M.2
  • 41
    • 12044256695 scopus 로고
    • Dominance analysis: A new approach to the problem of relative importance of predictors in multiple regression
    • Budescu DV. Dominance analysis: A new approach to the problem of relative importance of predictors in multiple regression. Psychol Bull 1993;114:542-551.
    • (1993) Psychol Bull , vol.114 , pp. 542-551
    • Budescu, D.V.1
  • 42
    • 77949399427 scopus 로고    scopus 로고
    • Estimation of population attributable fraction (PAF) for disease occurrence in a cohort study design
    • Laaksonen MA, Harkanen T, Knekt P, Virtala E, Oja H. Estimation of population attributable fraction (PAF) for disease occurrence in a cohort study design. Statistics Med 2010;29:860-874.
    • (2010) Statistics Med , vol.29 , pp. 860-874
    • Laaksonen, M.A.1    Harkanen, T.2    Knekt, P.3    Virtala, E.4    Oja, H.5
  • 44
    • 0027443759 scopus 로고
    • Depressive symptoms and Cd4 lymphocyte decline among HIV-infected men
    • Burack JH, BarrettDC, StallRD, ChesneyMA, EkstrandML, Coates TJ. Depressive symptoms and Cd4 lymphocyte decline among HIV-infected men. JAMA 1993;270:2568-2573.
    • (1993) JAMA , vol.270 , pp. 2568-2573
    • Burack, J.H.1    Barrettdc2    Stallrd3    Chesneyma4    Ekstrandml5    Coates, T.J.6
  • 45
    • 0035925774 scopus 로고    scopus 로고
    • Mortality, CD4 cell count decline, and depressive symptoms among HIVseropositive women. Longitudinal analysis from the HIV epidemiology research study
    • Ickovics JR, Hamburger ME, Vlahov D, et al. Mortality, CD4 cell count decline, and depressive symptoms among HIVseropositive women. Longitudinal analysis from the HIV epidemiology research study. JAMA 2001;285:1466-1474.
    • (2001) JAMA , vol.285 , pp. 1466-1474
    • Ickovics, J.R.1    Hamburger, M.E.2    Vlahov, D.3
  • 47
    • 84906842332 scopus 로고    scopus 로고
    • Predictors and correlates of adherence to combination antiretroviral therapy (ART) for chronic HIV infection: A meta-analysis
    • Langebeek N, Gisolf EH, Reiss P, et al. Predictors and correlates of adherence to combination antiretroviral therapy (ART) for chronic HIV infection: A meta-analysis. BMC Med 2014;12:142.
    • (2014) BMC Med , vol.12 , pp. 142
    • Langebeek, N.1    Gisolf, E.H.2    Reiss, P.3
  • 48
    • 84876100453 scopus 로고    scopus 로고
    • Adherence to antiretroviral treatment decreases during postpartum compared to pregnancy: A longitudinal electronic monitoring study
    • Gertsch A, Michel O, Locatelli I, et al. Adherence to antiretroviral treatment decreases during postpartum compared to pregnancy: A longitudinal electronic monitoring study. AIDS Patient Care STDs 2013;27:208-210.
    • (2013) AIDS Patient Care STDs , vol.27 , pp. 208-210
    • Gertsch, A.1    Michel, O.2    Locatelli, I.3
  • 50
    • 84907608856 scopus 로고    scopus 로고
    • Impact of an adherence program to antiretroviral treatment on virologic response in a cohort of multitreated and poorly adherent HIV-infected patients in Spain
    • Navarro J, Perez M, Curran A, et al. Impact of an adherence program to antiretroviral treatment on virologic response in a cohort of multitreated and poorly adherent HIV-infected patients in Spain. AIDS Patient Care STDs 2014;28:537-542.
    • (2014) AIDS Patient Care STDs , vol.28 , pp. 537-542
    • Navarro, J.1    Perez, M.2    Curran, A.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.